These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30099450)

  • 1. Once-a-Day Trazodone in the Treatment of Depression in Routine Clinical Practice.
    Češková E; Šedová M; Kellnerová R; Starobová O
    Pharmacology; 2018; 102(3-4):206-212. PubMed ID: 30099450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
    Olié JP; Gourion D; Montagne A; Rostin M; Poirier MF
    Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of trazodone retard monotherapy: results of the Serbian non-interventional study.
    Miljevic CD; Lečić-Toševski D; Trazodone Study Group Serbia
    Int J Psychiatry Clin Pract; 2016 Sep; 20(3):133-40. PubMed ID: 27335239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of trazodone once-a-day on quality of life and functional recovery in adults with major depressive disorder: A prospective, observational study.
    Tellone V; Markovic O; Strashimirova M; Sani G; Lenderking WR; Margolis MK; Fallone R; Quarchioni E; Cattaneo A; Comandini A
    Brain Behav; 2024 Jul; 14(7):e3580. PubMed ID: 39034363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative, randomised, double-blind study of trazodone prolonged-release and paroxetine in the treatment of patients with major depressive disorder.
    Kasper S; Olivieri L; Di Loreto G; Dionisio P
    Curr Med Res Opin; 2005 Aug; 21(8):1139-46. PubMed ID: 16083521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder.
    Sheehan DV; Rozova A; Gossen ER; Gibertini M
    Psychopharmacol Bull; 2009; 42(4):5-22. PubMed ID: 20581790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients.
    Saletu-Zyhlarz GM; Anderer P; Arnold O; Saletu B
    Neuropsychobiology; 2003; 48(4):194-208. PubMed ID: 14673218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
    Munizza C; Olivieri L; Di Loreto G; Dionisio P
    Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trazodone and ejaculatory inhibition.
    Kaufman KR; Marin H; Menza M
    J Sex Marital Ther; 2007; 33(3):225-30. PubMed ID: 17454520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Trazodone and venlafaxine in treatment of depressive disorders].
    Florkowski A; Gruszczyński W; Gałecki P; Zboralski K; Kołodziejska I; Mikołajczyk I
    Pol Merkur Lekarski; 2005 May; 18(107):556-9. PubMed ID: 16161955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of prolonged-release trazodone in major depressive disorder: a multicenter, randomized, double-blind, flexible-dose trial.
    Zhang L; Xie WW; Li LH; Zhang HG; Wang G; Chen DC; Cao Y; Cui LJ; Zhang KR; Shi JG; Tan QR; Zheng HB; Xu XF; Cheng ZH; Zhao JP
    Pharmacology; 2014; 94(5-6):199-206. PubMed ID: 25376160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.
    Jacobsen PL; Mahableshwarkar AR; Chen Y; Chrones L; Clayton AH
    J Sex Med; 2015 Oct; 12(10):2036-48. PubMed ID: 26331383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of oral trazodone slow release following intravenous administration in depressed patients: a naturalistic study.
    Fiorentini A; Rovera C; Caldiroli A; Arici C; Prunas C; Di Pace C; Paletta S; Pozzoli SM; Buoli M; Altamura AC
    Riv Psichiatr; 2018; 53(5):261-266. PubMed ID: 30353201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dystonia associated with trazodone and sertraline.
    Lewis CF; DeQuardo JR; Tandon R
    J Clin Psychopharmacol; 1997 Feb; 17(1):64-5. PubMed ID: 9004068
    [No Abstract]   [Full Text] [Related]  

  • 16. Trazodone plus pregabalin combination in the treatment of fibromyalgia: a two-phase, 24-week, open-label uncontrolled study.
    Calandre EP; Morillas-Arques P; Molina-Barea R; Rodriguez-Lopez CM; Rico-Villademoros F
    BMC Musculoskelet Disord; 2011 May; 12():95. PubMed ID: 21575194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult Chinese patients with treatment-resistant major depression.
    Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Cui X; Calabrese JR; Gao K;
    J Clin Psychopharmacol; 2011 Oct; 31(5):638-42. PubMed ID: 21869688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rediscovering trazodone for the treatment of major depressive disorder.
    Fagiolini A; Comandini A; Catena Dell'Osso M; Kasper S
    CNS Drugs; 2012 Dec; 26(12):1033-49. PubMed ID: 23192413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression.
    Maes M; Vandoolaeghe E; Desnyder R
    J Affect Disord; 1996 Dec; 41(3):201-10. PubMed ID: 8988452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venlafaxine extended-release: a review of its use in the management of major depression.
    Wellington K; Perry CM
    CNS Drugs; 2001; 15(8):643-69. PubMed ID: 11524036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.